Toxic rise of clozapine plasma concentrations in relation to inflammation

被引:104
作者
Haack, MJ
Bak, MLFJ
Beurskens, R
Maes, M [1 ]
Stolk, LML
Delespaul, PAEG
机构
[1] Univ Hosp Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[2] Psychiat Hosp Vijverdal, Maastricht, Netherlands
[3] Maastricht Univ, European Grad Sch Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[4] Psychiat Hosp Vijverdal, Dept Psychiat Rehabil, Maastricht, Netherlands
[5] Univ Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[6] Univ Hosp Maastricht, Dept Clin Pharm & Toxicol, Maastricht, Netherlands
[7] Maastricht Univ, Brain & Behav Inst, Maastricht, Netherlands
关键词
clozapine; P450; metabolism; infection; inflammation; cytokines; toxic;
D O I
10.1016/S0924-977X(03)00042-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recently a small number of patients were observed in two psychiatric hospitals in the Netherlands with clozapine intoxications that complicate or mimic infections. These patients were on chronic medication and normally had stable clozapine blood plasma levels. This article presents four of these cases. Medline was searched for reports of similar cases. A hypothesis was formulated and tested bit literature study. Immune modulatory and toxic effects of clozapine protein reactive metabolites or haptens, may play a role in the development of inflammation. Clozapine has a direct influence on different cytokines resembling an inflammatory reaction. Infection or inflammation could induce bioactivation of clozapine into its nitrenium ion that can exert a toxic reaction that induces apoptosis and gives rise to elevated cytokine levels. Clozapine can function as a hapten and induce an IgG, IgM or IgE mediated hypersensitivity reaction. The cytokines released during infection or inflammation downregulate the clozapine metabolism in the P450 system through CYP 1A2. Clozapine plasma levels should be monitored closely if an inflammatory or infectious process is suspected. (C) 2003 Elsevier B.V./ECNP. All rights reserved.
引用
收藏
页码:381 / 385
页数:5
相关论文
共 48 条
[1]   Pharmacokinetics of clozapine and risperidone: A review of recent literature [J].
Byerly, MJ ;
DeVane, CL .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (02) :177-187
[2]   Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients [J].
Carrillo, JA ;
Herraiz, AG ;
Ramos, SI ;
Benítez, J .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) :311-316
[3]   Erythromycin-induced clozapine toxic reaction [J].
Cohen, LG ;
Chesley, S ;
Eugenio, L ;
Flood, JG ;
Fisch, J ;
Goff, DC .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (06) :675-677
[4]   Clozapine plasma level monitoring: Current status [J].
Cooper, TB .
PSYCHIATRIC QUARTERLY, 1996, 67 (04) :297-311
[5]   The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine [J].
Eiermann, B ;
Engel, G ;
Johansson, I ;
Zanger, UM ;
Bertilsson, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) :439-446
[6]   Clozapine-induced acute interstitial nephritis [J].
Elias, TJ ;
Bannister, KM ;
Clarkson, AR ;
Faull, D ;
Faull, RJ .
LANCET, 1999, 354 (9185) :1180-1181
[7]  
FUNDERBURG LG, 1994, AM J PSYCHIAT, V151, P1840
[8]   Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia [J].
Guitton, C ;
Abbar, M ;
Kinowski, JM ;
Chabrand, P ;
Bressolle, F .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :470-476
[9]   Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia [J].
Guitton, C ;
Kinowski, JM ;
Abbar, M ;
Chabrand, P ;
Bressolle, F .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (07) :721-728
[10]   Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission:: effects of confounding factors and diagnosis [J].
Haack, M ;
Hinze-Selch, D ;
Fenzel, T ;
Kraus, T ;
Kühn, M ;
Schuld, A ;
Pollmächer, T .
JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (05) :407-418